retatrutide drug retatrutide Promises Big Weight Loss, but Safety Remains a Question Retatrutide, an experimental weight-loss drug,

Mass compounding of tirzepatide, the active ingredient in Mounjaro and Zepbound, was supposed to stop last month after the Food and Drug Administration declared the shortage of the drugs over

Individual variation is substantial, and some patients may never experience diarrhea at all, while others may have symptoms that persist longer before achieving tolerance

These molecular alterations indicate that GLP-1 may contribute to skin defects and impair epidermal function, making pups more vulnerable to environmental stressors

Ongoing dehydration, nutrient imbalances or poor sleep quality can also contribute to feeling chronically tired while taking GLP-1 medications

Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer

BMI doesnt reflect patterns